2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America

J Card Fail. 2016 Sep;22(9):659-69. doi: 10.1016/j.cardfail.2016.07.001. Epub 2016 Jul 6.


No abstract available

Keywords: AHA Scientific Statements; angioedema; angiotensin receptor blockers; angiotensin receptor-neprilysin inhibitor; angiotensin-converting enzyme inhibitors; beta blockers; focused update; heart failure; ivabradine; natriuretic peptides.

MeSH terms

  • Advisory Committees
  • American Heart Association / organization & administration
  • Forecasting
  • Heart Failure / diagnosis
  • Heart Failure / drug therapy*
  • Humans
  • Interdisciplinary Communication
  • Practice Guidelines as Topic*
  • Quality of Health Care*
  • Renin-Angiotensin System / drug effects
  • Societies, Medical / organization & administration
  • Stroke Volume / drug effects*
  • United States